Cargando…

Poor health and functioning in patients with axial spondyloarthritis during the COVID-19 pandemic and lockdown: REUMAVID study (phase 1)

AIM: To evaluate the overall health and functioning in patients with axial spondyloarthritis (axSpA) and related factors affecting these during the COVID-19 pandemic and lockdown measures. METHODS: Data from 587 axSpA patients participating in the first phase (April–July 2020) of the REUMAVID study...

Descripción completa

Detalles Bibliográficos
Autores principales: Benavent, Diego, Garrido-Cumbrera, Marco, Plasencia-Rodríguez, Chamaida, Marzo-Ortega, Helena, Christen, Laura, Correa-Fernández, José, Plazuelo-Ramos, Pedro, Webb, Dale, Navarro-Compán, Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777346/
https://www.ncbi.nlm.nih.gov/pubmed/35069810
http://dx.doi.org/10.1177/1759720X211066685
_version_ 1784637049826967552
author Benavent, Diego
Garrido-Cumbrera, Marco
Plasencia-Rodríguez, Chamaida
Marzo-Ortega, Helena
Christen, Laura
Correa-Fernández, José
Plazuelo-Ramos, Pedro
Webb, Dale
Navarro-Compán, Victoria
author_facet Benavent, Diego
Garrido-Cumbrera, Marco
Plasencia-Rodríguez, Chamaida
Marzo-Ortega, Helena
Christen, Laura
Correa-Fernández, José
Plazuelo-Ramos, Pedro
Webb, Dale
Navarro-Compán, Victoria
author_sort Benavent, Diego
collection PubMed
description AIM: To evaluate the overall health and functioning in patients with axial spondyloarthritis (axSpA) and related factors affecting these during the COVID-19 pandemic and lockdown measures. METHODS: Data from 587 axSpA patients participating in the first phase (April–July 2020) of the REUMAVID study who completed the ASAS Health Index (ASAS-HI) were analysed. REUMAVID is a cross-sectional study that collects data through an online survey to assess the impact of the COVID-19 pandemic on patients with rheumatic and musculoskeletal diseases across seven European countries. Poor health was defined as ASAS-HI ⩾ 12. The World Health Organization Five well-being index, self-perceived health status and change in health status during COVID-19 pandemic were evaluated as secondary outcomes. Logistic regression models were used to identify the factors associated with poor health. RESULTS: According to the ASAS-HI, 147 (25.0%) patients reported poor health. Pain and moving around were the main affected categories. In addition, 14.0% reported their self-perceived health status as ‘bad’ or ‘very bad’ and 46.8% as worse than before the pandemic. In the multivariate analysis, smoking (OR = 1.98), diabetes (OR = 4.89) and taking painkillers (OR = 2.82) or corticosteroids use (OR = 2.20) were significantly associated with poor health, while engaging in physical activity (OR = 0.54) and being actively employed (OR = 0.48) were inversely associated with this. CONCLUSIONS: During the first wave of the COVID-19 pandemic, one in four axSpA patients reported poor health and functioning, while the self-perceived health status of almost half of these patients worsened. Nonsmoking, physical activity and being employed were associated with better outcomes.
format Online
Article
Text
id pubmed-8777346
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-87773462022-01-22 Poor health and functioning in patients with axial spondyloarthritis during the COVID-19 pandemic and lockdown: REUMAVID study (phase 1) Benavent, Diego Garrido-Cumbrera, Marco Plasencia-Rodríguez, Chamaida Marzo-Ortega, Helena Christen, Laura Correa-Fernández, José Plazuelo-Ramos, Pedro Webb, Dale Navarro-Compán, Victoria Ther Adv Musculoskelet Dis Original Research AIM: To evaluate the overall health and functioning in patients with axial spondyloarthritis (axSpA) and related factors affecting these during the COVID-19 pandemic and lockdown measures. METHODS: Data from 587 axSpA patients participating in the first phase (April–July 2020) of the REUMAVID study who completed the ASAS Health Index (ASAS-HI) were analysed. REUMAVID is a cross-sectional study that collects data through an online survey to assess the impact of the COVID-19 pandemic on patients with rheumatic and musculoskeletal diseases across seven European countries. Poor health was defined as ASAS-HI ⩾ 12. The World Health Organization Five well-being index, self-perceived health status and change in health status during COVID-19 pandemic were evaluated as secondary outcomes. Logistic regression models were used to identify the factors associated with poor health. RESULTS: According to the ASAS-HI, 147 (25.0%) patients reported poor health. Pain and moving around were the main affected categories. In addition, 14.0% reported their self-perceived health status as ‘bad’ or ‘very bad’ and 46.8% as worse than before the pandemic. In the multivariate analysis, smoking (OR = 1.98), diabetes (OR = 4.89) and taking painkillers (OR = 2.82) or corticosteroids use (OR = 2.20) were significantly associated with poor health, while engaging in physical activity (OR = 0.54) and being actively employed (OR = 0.48) were inversely associated with this. CONCLUSIONS: During the first wave of the COVID-19 pandemic, one in four axSpA patients reported poor health and functioning, while the self-perceived health status of almost half of these patients worsened. Nonsmoking, physical activity and being employed were associated with better outcomes. SAGE Publications 2022-01-19 /pmc/articles/PMC8777346/ /pubmed/35069810 http://dx.doi.org/10.1177/1759720X211066685 Text en © The Author(s), 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Benavent, Diego
Garrido-Cumbrera, Marco
Plasencia-Rodríguez, Chamaida
Marzo-Ortega, Helena
Christen, Laura
Correa-Fernández, José
Plazuelo-Ramos, Pedro
Webb, Dale
Navarro-Compán, Victoria
Poor health and functioning in patients with axial spondyloarthritis during the COVID-19 pandemic and lockdown: REUMAVID study (phase 1)
title Poor health and functioning in patients with axial spondyloarthritis during the COVID-19 pandemic and lockdown: REUMAVID study (phase 1)
title_full Poor health and functioning in patients with axial spondyloarthritis during the COVID-19 pandemic and lockdown: REUMAVID study (phase 1)
title_fullStr Poor health and functioning in patients with axial spondyloarthritis during the COVID-19 pandemic and lockdown: REUMAVID study (phase 1)
title_full_unstemmed Poor health and functioning in patients with axial spondyloarthritis during the COVID-19 pandemic and lockdown: REUMAVID study (phase 1)
title_short Poor health and functioning in patients with axial spondyloarthritis during the COVID-19 pandemic and lockdown: REUMAVID study (phase 1)
title_sort poor health and functioning in patients with axial spondyloarthritis during the covid-19 pandemic and lockdown: reumavid study (phase 1)
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777346/
https://www.ncbi.nlm.nih.gov/pubmed/35069810
http://dx.doi.org/10.1177/1759720X211066685
work_keys_str_mv AT benaventdiego poorhealthandfunctioninginpatientswithaxialspondyloarthritisduringthecovid19pandemicandlockdownreumavidstudyphase1
AT garridocumbreramarco poorhealthandfunctioninginpatientswithaxialspondyloarthritisduringthecovid19pandemicandlockdownreumavidstudyphase1
AT plasenciarodriguezchamaida poorhealthandfunctioninginpatientswithaxialspondyloarthritisduringthecovid19pandemicandlockdownreumavidstudyphase1
AT marzoortegahelena poorhealthandfunctioninginpatientswithaxialspondyloarthritisduringthecovid19pandemicandlockdownreumavidstudyphase1
AT christenlaura poorhealthandfunctioninginpatientswithaxialspondyloarthritisduringthecovid19pandemicandlockdownreumavidstudyphase1
AT correafernandezjose poorhealthandfunctioninginpatientswithaxialspondyloarthritisduringthecovid19pandemicandlockdownreumavidstudyphase1
AT plazueloramospedro poorhealthandfunctioninginpatientswithaxialspondyloarthritisduringthecovid19pandemicandlockdownreumavidstudyphase1
AT webbdale poorhealthandfunctioninginpatientswithaxialspondyloarthritisduringthecovid19pandemicandlockdownreumavidstudyphase1
AT navarrocompanvictoria poorhealthandfunctioninginpatientswithaxialspondyloarthritisduringthecovid19pandemicandlockdownreumavidstudyphase1